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Abstract Significant progress in understanding the effects of
the neurotoxic action of lead (Pb) in young organisms had led
to reduction of Bsafe^ level in the blood (Pb-B) to 5 μg/dL in
children and pregnant women. Prolonged exposure to relative-
ly low levels of Pb, generally asymptomatic and subclinical
(i.e., microintoxication), is currently the dominant form of
environmental poisoning, and its negative effects on health
may appear after many years, e.g., secondary contamination
from Pb bone deposits released in pregnancy. Therefore, the
aim of this study was to investigate the effect of environmental
exposure (urban areas) of mothers to Pb, on its levels in their
milk and blood and in the blood of newborns. Moreover, the
aim was to determine the fatty acid profile in the mothers’
blood and milk and in the blood of newborns. We also wanted
to find if infant birth weight depends on Pb blood levels, as
well as on Pb and fatty acid levels in the blood and milk of the
mothers. Finally, we examined if the mothers’ weight and
body mass index (BMI) before pregnancy influenced the con-
centration of Pb and fatty acid profile in the blood and milk of
mothers and in the blood of their children. Analysis of fatty
acids elaidic (C18:1, 9t), oleic (C18:1, 9c), vaccenic (C18:1,
11t), cis-vaccenic (C18:1, 11c), linoleic (C18:2, cis), γ-
linolenic (C18:3, n-6), α-linolenic (C18:3, n-3), arachidonic
(C20:4, n-6), eicosapentaenoic (C20:5, n-3), and
docosahexaenoic (C22:6, n-3) was conducted by gas chroma-
tography. The concentration of Pb in the whole blood andmilk
were determined by atomic absorption spectrometry with
graphite furnace atomization and Zeeman correction. Our
study established a significant and strong correlation between
the content of Pb in the blood of the mother and the child. This
supports the assumption that the transport of Pb through the
placenta is neither regulated nor selective. Environmental ma-
ternal exposure to lead resulting in Pb-B levels considered safe
for pregnant women had no effect on infant birth weight, the
concentration of fatty acids in the blood and milk of mothers,
or in the blood of newborns. Mothers’weight and BMI before
pregnancy had no effect on the concentration of Pb and stud-
ied fatty acid profile.
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Introduction
Lead (Pb) is a metal which is commonly present in the envi-
ronment and exerts a toxic effect on many organs of the hu-
man body [1–3]. The concentration of Pb in living organisms
is closely related to anthropogenic environmental contamina-
tion. In developed countries, growing awareness of its effects
on human health has resulted in efforts to restrict its use [3, 4].
However, on a global scale, the total level of Pb emissions into
the atmosphere is still high. Moreover, lead compounds are
not biodegradable and therefore the current levels of environ-
mental Pb contamination cannot be effectively reduced [4–6].
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A primary target for lead is the developing central nervous
system. Acute Pb contamination in children (lead concentra-
tion in whole blood—Pb-B >70 μg/dL), which is currently
very rare, can have a dramatic effect on the central nervous
system, i.e., brain edema, convulsions, coma, and lead en-
cephalopathy [6]. Pb poisoning in children on a scale unheard
of for decades has been detected in rural northwestern Nigeria.
A total of 161 deaths in two villages have been attrib-
uted to an incident from May 2009 to May 2010, with
hundreds and potentially thousands more people becom-
ing seriously ill [7, 8].
Significant progress in understanding the effects of the neu-
rotoxic action of Pb in young organisms had led to the creation
of a system of diagnosis and treatment of lead poisoning and a
gradual reduction of Bsafe^ levels in the blood to 10 μg/dL [9,
10]. In children and pregnant women, the permissible dose is
5 μg/dL [3]. At the same time, prolonged exposure to relative-
ly low levels of lead, generally asymptomatic and subclinical
(i.e., microintoxication), is currently the dominant form of
environmental poisoning and its negative effects on health
may appear after many years, e.g., secondary contamination
from Pb bone deposits released in pregnancy [11]. This means
that pregnant women should be monitored for Pb exposure
which may result in miscarriage, premature birth, low birth
weight, and neonatal malformations [12, 13]. Many studies
have also indicated that Pb levels considered safe can have a
neurotoxic effect on the developing brain in the pre- and neo-
natal period of life [14, 15].
A woman’s body during pregnancy is burdened with
additional functions. It must create the right environ-
ment and provide the necessary elements to the devel-
oping fetus. One such component is lipids; the lipid
profile of a pregnant woman changes to provide energy
security for both the mother and child [16]. Of particu-
lar importance are the fatty acids that play an important
role as building blocks and a source of energy, acting
also as a very important component for the proper de-
velopment of the brain. After birth, the mother’s body
plays an important role in securing energy through the
production of milk with high amounts of fatty acids.
Thus, the mother’s body during pregnancy and breast-
feeding is the only source of fatty acids for the child
[17]. At the same time, the same route is used by toxic
substances that enter the body of the child, including
lead.
Therefore, the aim of this study was to investigate the effect
of environmental exposure of mothers to lead, on Pb levels in
their milk and blood and in the blood of newborns. Moreover,
the aim was to determine the fatty acid profile in the mothers’
blood and milk and in the blood of newborns. We also wanted
to find if infant birth weight depends on Pb blood levels, as
well as on Pb and fatty acid levels in the blood and milk of the
mothers. Finally, we examined if the mothers’ weight and
body mass index (BMI) before pregnancy influenced the con-
centration of Pb and fatty acid profile in the blood and milk of
mothers and in the blood of their children.
Material and Methods
Characteristics of the Study Group
In order to conduct this study, we obtained the consent of the
Bioethics Committee at the PomeranianMedical University in
Szczecin (No. BN-001/02/07). Before giving written consent,
each patient received full information about the purpose and
plan of study.
The study involved 53 female patients of the Clinic of
Obstetrics and Perinatology of the Pomeranian Medical
University in Szczecin and their newborns. The patients come
from urban areas. The survey was conducted from June to
August in 2007 and 2008. Forty-nine newborns were born
vaginally and four by caesarean section due to the lack of
progress of labor. Each pregnant woman was qualified for
the study after exclusion of any pathology in pregnancy and
coexisting chronic diseases which preceded the pregnancy.
The mean age of patients was 29.11 years. During the study,
32 women were primigravidas, while 21 women were
multigravidas. None of the women had had multiple pregnan-
cies, while nine subjects had a history of miscarriages. Fifty
newborn babies were born after 37 weeks of gestation, two in
the 37th week and one at the 36th week of gestation. All
children exhibited functional and morphological maturity, ad-
equate for gestational age (Table 1).
Collection of Blood and Milk
Blood samples were collected from mothers in the first stage
of labor; 9 ml of blood was collected from the cubital vein into
tubes containing EDTA as an anticoagulant. Also, 9 ml of
blood was collected from umbilical vein into tubes with
EDTA after the cord separation. The collected samples were
placed at 4 °C and transported within 10 min to the laboratory
of the Department of Biochemistry of the Pomeranian
Medical University. There they were centrifuged at 1800×g
for 10 min at 4 °C. The plasma obtained by centrifugation was
purged with nitrogen, then frozen and stored at −80 °C until
analysis of a given material.
At 5–6 weeks postpartum, an Avent manual breast pump
was used to sample approx. 30 mL of breast milk. Milk sam-
ples were taken in the morning, after feeding. The samples
were then transported on ice to the laboratory of the
Department of Biochemistry of the Pomeranian Medical
University and purged with nitrogen. After this, the samples
were frozen at −80 °C within 1 h of collection until analysis.
280 Baranowska-Bosiacka et al.
Extraction and Analysis of Fatty Acids
Lipids from the samples were extracted using the Folch mix-
ture. Then, the samples were hydrolyzed to give fatty acids
which were transformed into fatty acid methyl esters
(FAMEs). By adding 0.5 % solution of BHT, fatty acids were
secured against the oxidation reaction. FAME in hexane solu-
tion was injected onto the capillary column (CP-SIL88
50 M × 0.25 mm ID, film thickness 0.2 μm, Varian) of the
6890M Agilent gas chromatograph equipped with an
autosampler. FAMEs were mobile in the column in an atmo-
sphere of hydrogen as a carrier gas. The initial temperature
was about 100 °C and maintained for 1 min, then the temper-
ature was increased at a rate of 10 °C/min to 180 °C, then at a
rate of 3 °C/min to 205 °C, and then at a rate of 10 °C/min to
220 °C. Identification of geometric and positional fatty acid
isomers was carried out on the basis of a comparison of reten-
tion times with the Sigma-Aldrich fatty acid standards. The
concentrations of fatty acids were determined based on stan-
dard curves and expressed in milligrams per milliliter.
Further analyses took into account the following fatty
acids: elaidic (C18:1, 9t), oleic (C18:1, 9c), vaccenic (C18:1,
11t), cis-vaccenic (C18:1, 11c), linoleic (C18:2 c), γ-linolenic
(C18:3, n-6), α-linolenic (C18:3, n-3), arachidonic (C20:4, n-
6), eicosapentaenoic (C20: 5, n-3), and docosahexaenoic acid
(C22:6, n-3).
Determination of the Concentration of Lead in Blood
and in Milk
The concentration of lead in whole blood (B-Pb) was mea-
sured by means of graphite furnace atomic absorption spec-
trometry. The procedure was based on the Stoepper et al.
method for determination of lead in deproteinized blood sam-
ples by electrothermal atomization technique [18]. After
deproteinization of blood with 0.8 M nitric acid, the samples
were analyzed using the Perkin Elmer 4100ZL atomic absorp-
tion spectrometer equipped with Zeeman background correc-
tion system and autosampler. The calibration was performed
by matrix-match calibration standards. The detection limit
was 2 μg/L and precision of the method σ% = 4.4. The results
for BCR 194 and BCR 195 certificate reference materials with
certificated values of mean 122–130 and 407–425 μg/L were
123 ± 5 and 408 ± 15μg/L (n = 23), respectively. The analysis
was performed at the Institute of Occupational Medicine and
Environmental Health in a laboratory that regularly participat-
ed in two proficiency tests (Lead and Multielement
Proficiency—CDC in Atlanta and METOS Program—
Istituto Superiore di Sanita in Rome) and fulfilled the require-
ments of the study organizers.
Lead in milk was determined after mineralization 1 mL of
milk with 1 mL of concentrated nitric acid (Baker Instra-
Analyzed) under pressure. The samples were subsequently
evaporated nearly to dryness and redissolved to 1 mL with
0.8 M nitric acid. The resulted solution was analyzed for lead
concentration with graphite furnace atomic absorption spec-
trometry technique (Perkin Elmer 4100ZL) against aqueous
standards prepared on diluted (0.8 M) nitric acid. The detec-
tion limit was 0.5 μg/L and trueness based on Seronorm
(201405) control material (due to the lack of Certified
Reference Materials in liquid form for trace elements) with
declared value for lead 2.9 ± 0.2 μg/L was 92 %.
Statistical Analysis
Anthropometric data and concentrations of selected acids in
milk and blood of mothers and children were presented as
arithmetic means (x ± SD), medians, and in ranges (max-
min). Based on body mass and height (B-v) of mothers,
BMI was calculated (BMI = body weight [kg] / height of the
body [m]2) for the time before pregnancy and after childbirth.
The results were interpreted based on the WHO classification,
where BMI ≤18.49 is insufficient body weight, BMI 18.50–
24.99 is a normal range, BMI ≥25.00–29.99 denotes over-
weight, and BMI ≥30.00 means obesity [19].
The distribution of variables was evaluated using the
Shapiro-Wilk W test. As the distribution of variables was not
deviated from normal distribution, parametric tests were used
for further analyses. Pearson correlation analysis was per-
formed to determine the strength of correlation between the
variables. The average concentrations in the analyzed milk,
maternal blood, and fetal blood were compared by one-way
analysis of variance (ANOVA) for variables with a normal
distribution. When the analysis of variance showed that the
Table 1 Descriptive statistics (n = 53)
Variable x ± SD Median Min-max CV (%)
Maternal age 29.11 ± 4.77 29.00 18.00–39.00 0.52103
Neonatal birth weight (g) 3511.70 ± 497.75 3570.00 2470.00–4350.00 0.38984
Maternal body weight before pregnancy (kg) 62.94 ± 12.12 61.00 44.00–100.00 0.54997
Maternal prepregnancy BMI 22.60 ± 3.85 21.48 17.63–34.37 0.54997
Postpartum maternal weight (kg) 79.69 ± 13.76 77.00 57.70–120.00 0.49581
Postpartum BMI 28.64 ± 4.48 27.93 21.99–42.52 0.44223
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compared means differed significantly, post hoc tests were
performed to investigate differences between the means of
each group. Comparisons were made with the Tukey’s range
test. Tests were evaluated at the significance level p ≤ 0.05.
Results
Body Mass Index
Before pregnancy, 11.3 % (n = 6) of the surveyed women had
an insufficient weight, 64.2 % (n = 34) had a weight in a
normal BMI range, 17 % (n = 9) were overweight, and
7.5 % (n = 4) were obese, according to BMI classification.
Pb Concentration in Maternal and Neonatal Blood
and in Milk
The highest average concentration of Pb was found in mater-
nal blood (1.290 μg/dL ±0.578) and the lowest in milk
(0.174 μg/dL ±1.15). On the basis of correlation analysis,
we demonstrated a significant and strong correlation between
the concentration of maternal blood Pb and neonatal blood Pb
(Rs = 0.61; p ≤ 0.0001). We also found a weak but statistically
significant (Rs = 0.31; p = 0.048) correlation between the
concentration of Pb in the neonatal blood and the concentra-
tion of vaccenic acid (C18: 1, 9t) in maternal blood (Fig. 1).
Elaidic Acid (C18: 1, 9t) in Maternal and Neonatal Blood
and in Milk
The highest average concentration of elaidic acid was
determined in milk (0.273 mg/mL ±0.19). The lowest
concentration of the acid was observed in the neonatal
blood (0.002 mg/mL ±0.001).
Correlation analysis revealed a significant and strong cor-
relation between elaidic and vaccenic acid levels in the
mothers’ blood (Rs = 0.85; p = 0.0001) and milk
(Rs = 0.55; p = 0.0001). A weaker correlation between these
acids occurred in the neonatal blood (Rs = 0.45; p = 0.001). A
significant correlation was also found between elaidic acid
and γ-linolenic acid in milk (Rs = 0.48; p = 0.0001) (Table 2).
Oleic Acid (C18: 1, 9c) in Maternal and Neonatal Blood
and in Milk
The highest average level of oleic acid was observed in milk
(15.068 mg/mL ±6.92), while the smallest in the neonatal
blood (0.173 mg/mL ±0.054).
Correlation analysis showed a very strong correlation be-
tween oleic acid and C18: 1, 11c in all three cases (milk
Rs = 0.95, p ≤ 0.01; maternal blood Rs = 0.90, p ≤ 0.001;
the neonatal blood of Rs = 0.93, p ≤ 0.001). A significant
(p ≤ 0.0001) and also a strong correlation was found between
oleic acid and the following acids: linoleic acid in milk
(Rs = 0.90), in maternal blood (Rs = 0.73), and neonatal blood
(Rs = 0.80); γ-linolenic acid in milk (Rs = 0.83) and in the
neonatal blood (Rs = 0.55); α-linolenic acid in milk
(Rs = 0.78); arachidonic acid in milk (Rs = 0.91), maternal
blood (Rs = 0.63), and neonatal blood (Rs = 0.75);
e icosapentaenoic acid in milk (Rs = 0.68) ; and
docosahexaenoic in milk (Rs = 0.71), maternal blood
(Rs = 0.62), and neonatal blood (Rs = 0.62). A significant
(p = 0.0001) and a moderately strong correlation occurred
between oleic acid and γ-linolenic acid in the neonatal blood
(Rs = 0.55) and α-linolenic acid in maternal blood
(Rs = 0.47).
Cis-Vaccenic Acid (C18: 1, 11c) in Maternal and Neonatal
Blood and in Milk
Also in the case of cis-vaccenic acid, the highest average con-
centrations are found in milk (0.931 mg/mL ±0.464) and the
lowest in the neonatal blood (0.020 mg/mL ±0.009).
On the basis of the correlation analysis, we found showed a
significant (p = 0.0001) and a strong correlation between the
acid C18:1, 11c and the following acids: linoleic acid in milk
(Rs = 0.84), maternal blood (Rs = 0.65), and neonatal blood
(Rs = 0.74); γ-linolenic acid in milk (Rs = 0.78); α-linolenic
acid in milk (Rs = 0.71); arachidonic acid in maternal blood
(Rs = 0.61) and neonatal blood (Rs = 0.76); eicosapentaenoic
acid in milk (Rs = 0.64); and docosahexaenoic acid in milk
(Rs = 0.71). There was a significant (p = 0.0001) but moder-
ately strong correlation between vaccenic acid in maternal
blood (Rs = 0.47), γ-linolenic acid in the neonatal blood
(Rs = 0.47) and docosahexaenoic acid in maternal blood

























Fig. 1 The concentration of lead (Pb) in maternal and neonatal blood and
in milk. **Statistically significant difference between the level of Pb in
the mother’s blood and breast milk (p < 0.001). ###Statistically signifi-
cant difference between the content of Pb in the neonatal blood and in the
milk (p < 0.0001). ^^^Statistically significant difference between the
content of Pb in the blood of mother and neonate (p < 0.0001)
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Vaccenic Acid (C18: 1, 11t) in Maternal and Neonatal
Blood and in Milk
The highest average concentration of vaccenic acid has been
identified in milk (0.292 mg/mL ±0.202) and the smallest in
the neonatal blood (0.0003 mg/mL ±0.002).
The correlation between the concentration of vaccenic acid
concentrations and other acids was placed in U.S. preceding
acids.
Linoleic Acid (C18: 2, cis) inMaternal andNeonatal Blood
and Milk
As in all previous acids, also in the case of linoleic acid, the
highest average concentration is found in milk (5.953 mg/mL
±3.012) and the lowest in the neonatal blood (0.135 mg/mL
±0.41).
Correlation analysis revealed a significant (p = 0.0001) and
strong correlation between linoleic acid and the following
acids: γ-linolenic acid in milk (Rs = 0.76); α-linolenic acid
in milk (Rs = 0.80) and maternal blood (Rs = 0.66); arachi-
donic acid in milk (Rs = 0.86), maternal blood (Rs = 0.64),
and neonatal blood (Rs = 0.71); eicosapentaenoic acid in milk
(Rs = 0.60); and docosahexaenoic acid in the neonatal blood
(Rs = 0.69). A significant (p = 0.0001) but weaker correlation
was found between linoleic acid and γ-linolenic acid in the
neonatal blood (Rs = 0.47), α-linolenic acid in neonatal blood
(Rs = 0.55), and docosahexaenoic acid in maternal blood
(Rs = 0.56).
γ-Linolenic Acid (C18: 3, n-6 Gamma) in Maternal
and Neonatal Blood and in Milk
The greatest concentration of γ-linolenic acid was determined
in milk (0.095 mg/mL ±0.030), and the lowest in the neonatal
blood (0.044 mg/mL ±0.002).
Based on the analysis of the correlation, a significant
(p = 0.0001) and strong correlation was observed between
γ-linolenic acid and arachidonic acid in milk (Rs = 0.78)
and between γ-linolenic acid and eicosapentaenoic acid in
milk (Rs = 0.60). A significant (p = 0.0001) but statistically
less strong correlation occurred between γ-linolenic acid and
α-linolenic acid in milk (Rs = 0.54), arachidonic acid in the
maternal blood (Rs = 0.51), and docosahexaenoic acid in milk
(Rs = 0.49).
α-Linolenic Acid (C18: 3, n-3 Linolenic Acid) in Maternal
and Neonatal Blood and in Milk
The highest average level of α-linolenic acid was determined
in milk (0.855 mg/mL ±0.466) while the lowest in neonatal
blood (0.004 mg/mL ±0.003).
Table 2 The content of fatty
acids in maternal and neonatal
blood and in milk
Fatty acid Neonatal blood (mg/mL) Maternal blood (mg/mL) Milk (mg/mL)
Elaidic acid
C18:1, 9t
0.002 ± 0.001^^^ 0.014 ± 0.009 0.273 ± 0.194***,###
Oleic acid
C18:1, 9c
0.173 ± 0.054^^^ 1.065 ± 0.305 15.068 ± 6.913***,###
Vaccenic acid
C18:1, 11c
0.020 ± 0.009^^^ 0.079 ± 0.030 0.931 ± 0.464***,###
Vaccenic acid
C18:1, 11t
0.0003 ± 0.002^^^ 0.010 ± 0.006 0.292 ± 0.202***,###
Linoleic acid
C18:2, n-6 c
0.135 ± 0.041^^^ 1.165 ± 0.253 5.953 ± 3.012***,###
γ-Linolenic acid
C18:3, n-6 c
0.044 ± 0.002^^^ 0.052 ± 0.009 0.095 ± 0.030***,###
α-Linolenic acid
C18:3, n-3 c
0.004 ± 0.003^^^ 0.058 ± 0.017 0.855 ± 0.466***,###
Arachidonic acid
C20:4, n-6 c
0.154 ± 0.043^^^ 0.267 ± 0.070 0.225 ± 0.111*,##
Eicosapentaenoic acid
C20:5, n-3
0.005 ± 0.004^^^ 0.025 ± 0.034 0.039 ± 0.024***,###
Docosahexaenoic acid
C22:6, n-3
0.058 ± 0.022^^^ 0.128 ± 0.050 0.127 ± 0.066###
^^^Statistically significant difference in the fatty acid level between thematernal and neonatal blood (p < 0.0001);
***statistically significant difference in the fatty acid level between the maternal blood and milk (p < 0.0001);
*statistically significant difference in the fatty acid level between the maternal blood and milk (p < 0.01);
###statistically significant difference in the fatty acid level between the neonatal blood and milk (p < 0.01);
##statistically significant difference in the fatty acid level between the neonatal blood and milk (p < 0.001)
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Correlation analysis revealed a significant (p = 0.0001) and
a strong correlation between the α-linolenic acid and arachi-
donic acid in milk (Rs = 0.71), eicosapentaenoic acid in milk
(Rs = 0.67), and docosahexaenoic acid also in milk
(Rs = 0.63). A significant (p = 0.0001) but weaker correlation
was found between α-linolenic acid and docosahexaenoic ac-
id in maternal blood (Rs = 0.47) and neonatal blood
(Rs = 0.55) (Table 2).
Arachidonic Acid (C20: 4, n-6) in Maternal and Neonatal
Blood and in Milk
Unlike previous acids, the highest average concentration of
arachidonic acid was fond in maternal blood (0.267 mg/mL
±0.070), while the lowest in neonatal blood (0.154 mg/mL
±0.043).
Correlation analysis showed a significant (p = 0.0001) and
strong correlation between the arachidonic acid and
e icosapentaenoic ac id in mi lk (Rs = 0.71) and
docosahexaenoic acid in milk (Rs = 0.77) and maternal blood
(Rs = 0.75). An equally significant (p = 0.0001) but weaker
correlation was determined between the arachidonic acid and
docosahexaenoic acid in neonatal blood of the child
(Rs = 0.58) (Table 2).
Eicosapentaenoic Acid (C20: 5 n-3) in Maternal
and Neonatal Blood and in Milk
In the case of eicosapentaenoic acid, the highest average con-
centration was observed in milk (0.039 mg/mL ±0.024), while
the lowest in neonatal blood (0.005 mg/mL ±0.004).
Correlation analysis showed a significant and strong corre-
lation between eicosapentaenoic acid and docosahexaenoic
acid in milk (p = 0.0001, Rs = 0.78) (Table 2).
Docosahexaenoic Acid (C22: 6, n-3) in Maternal
and Neonatal Blood and in Milk
The highest concentration of docosahexaenoic acid was found
in maternal blood (0.128 mg/mL ±0.050). The lowest concen-
tration of the acid occurred in neonatal blood (0.058 mg/mL
±0.022). There were no significant correlations between the
studied parameters for docosahexaenoic acid (Table 2).
Discussion
This is the first study on the effect of environmental exposure
to Pb on the fatty acid profile in the mothers’ blood and milk
and in the blood of newborns. Our results showed, that Pb-B
values in the mothers blood was below levels considered safe
for pregnant women, e.g. below 5 μg/dL [3]. Pb content in all
blood samples from the newborns were also inside the safe
levels. This indicates that mothers were not exposed to high
Pb concentrations before and during pregnancy. They were
representative for the area characterized bymoderate Pb levels
in the environment. The results are consistent with previous
studies on the transport of Pb through the placenta to the cord
blood [20, 21]. Our study also showed a significant and strong
correlation between Pb levels in the blood of the mother and
the child. This supports the idea that the transport of Pb
through the placenta is neither regulated nor selective [21].
Awoman’s body during pregnancy is burdened with addition-
al demands. It must create the right conditions for the growth
of the fetus and provide it with all the elements necessary for
development—hence the importance of a correct diet. One of
the nutrients necessary for the proper development of the fetus
is lipids. The lipid profile of a pregnant woman changes to
ensure energy security for both her and the fetus. The mother’s
body increases its absorption of lipids and raises their concen-
tration in the blood. The concentrations of total cholesterol
and VLDL, LDL, HDL, and TG increase along with the de-
velopment of gestation [16].
In the body of the developing fetus, fatty acids are trans-
ferred mainly to the cytoplasm of fat cells, where they can be
subjected to oxidation, multiplication of double bonds in the
molecule, or extension of the molecule. The other main site of
fatty acid occurrence is cellular structures, especially phos-
pholipids. The type of acid that is built in phospholipids de-
cides the fluidity of the membrane structure and function of
membrane receptors and enzymes. Studies have shown that
dietary trans-unsaturated fatty acids (TFAs) are more actively
incorporated into the cell membrane than cis-unsaturated fatty
acids [17]. Although placental transfer of saturated and cis-
unsaturated fatty acids has been demonstrated in rats, very few
studies have investigated the placental transport of trans-fatty
acids, and the obtained results are contradictory [22–24].
A study of Larqué et al. [25] shows that trans-fatty acids
are incorporated into plasma and liver microsomes of pregnant
rats in high concentrations and according to their profile and
content in the diets; however, this is shown not to occur in the
brain. The placenta also incorporates high amounts of trans-
isomers into its structure. However, this barrier is not
completely impermeable, inasmuch as a number of trans-fatty
acids cross the barrier and accumulate in the liver of the fetus,
showing a clear exposure of fetal tissues to maternal dietary
trans-fatty acids. This reflects the protective mechanisms
serving to limit the incorporation of TFAs in the central ner-
vous system [25, 26].
However, it is uncertain whether exposure to TFA in early
human life has adverse consequences. Studies on animals
show different explanations of TFA incorporation in human
tissues and the biological consequences of this process in the
neonatal period and during lactation. It has been shown that
animals born by mothers fed a diet rich in TFA had signifi-
cantly lower concentrations of those acids in their blood
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compared to maternal blood. Some amounts of trans-FAs
reach the placenta but are probably catabolized in fetal tissues
or replaced by the newly synthesized FAs [26]. In our re-
search, we also observed a much lower concentration of FAs
in the children’s blood compared to maternal blood. This may
be a confirmation of the proposition that FA are metabolized
in placenta tissues or that there are some mechanisms
inhibiting the transport of high FA concentrations through
the placenta. In our study, however, we found no correlation
between individual fatty acids in the mother’s blood and
baby’s blood.
The concentration of fats in milk increases significantly
during breast-feeding. The main fatty acids in milk are satu-
rated fatty acids, half of which is palmitic acid. These acids
can be synthesized de novo in the tissues of the body or may
be provided with the diet of mother. Cis-unsaturated fatty
acids are mainly represented by 18:1 9c (oleic acid).
Although monoene fatty acids are not essential and can be
synthesized, their intake with diet may have positive physio-
logical effects on the fluidity of cell membranes and choles-
terol metabolism.
The content of trans-unsaturated fatty acids in human
breast milk is estimated to be 4.4 %, with the main trans-
isomer being C18:1 11t (vaccenic acid), followed by isomers
14:1t, 16:1t, and 20:1t [27]. The concentrations of unsaturated
fatty acids in our study showed the highest concentration of
oleic acid and the smallest of eicosapentaenoic acid (Table 2).
Vaccenic and elaidic acids had the highest concentrations
among trans-unsaturated fatty acids.
The types of lipids present in breast milk depend on the diet
[17, 28], similar to the total amount of TFA. Their presence
may limit the availability of long-chain polyunsaturated fatty
acids (LC-PUFAs). Because LC-PUFAs are very important
for the early development of eyesight and cognitive abilities,
factors that reduce their availability after birth are a serious
issue [29]. However, until recently, this role of LC-PUFAs has
been controversial. Some studies show an inverse correlation
between the concentration of TFA 18:1 and PUFAs n-3 and n-
6 in breast milk and blood of the newborn. Desci et al. [28]
showed that in the lipids of umbilical vascular walls an in-
creased concentration of TFA C18:1 is associated with de-
creased levels of docosahexaenoic acid. This relationship
has been confirmed by other authors, for example Elias and
Innis [30]. However, other studies show no connection be-
tween these two groups of fatty acids, similar to the results
of the present study [31]. A negative correlation between
TFAs and PUFAs results from the inhibition of LC-PUFA
synthesis by TFA, which is confirmed in research conducted
on rats and in vitro on rat tissues and human fibroblasts.
However, in that case, it was impossible to make a clear state-
ment because of other works which show that the inhibitory
action of TFAs is observed only at high levels which are not
normally found in the diet [17].
The inhibitory effect is postulated to be associated with
disorders of enzymatic conversion of linoleic acid to arachi-
donic acid, documented in studies on animal models and in
human fibroblasts in vitro. It is assumed that TFAs are incor-
porated into the cell membrane and inhibit the metabolic con-
version of 18:2n-6 and 18:3n-3 to the longer chains of n-6 and
n-3 PUFAs. A significant decrease of n-6 and n-3 acids ob-
served in this study represents the effect of TFAs on the
desaturation and chain elongation of 18:2n-6 and 18:3n-3,
which indicates a loss of metabolic properties [32]. The cur-
rent study demonstrates that there is an inverse correlation not
only between TFAs and LC-PUFAs as well as between TFAs
and the substrate/product ratio in the synthesis of LC-PUFAs
but also between TFAs and linoleic acid in cholesterol esters.
However, it is not known yet whether this could have a con-
nection with the inhibition of the biosynthesis or if the result is
a combination of these two processes [29].
One of the dependencies that we investigated in this study
was the correlation between the studied FAs and BMI before
and after pregnancy. The results of our study showed no such
correlation. FAs did not correlate with maternal body weight
before and after pregnancy. This may have been due to the fact
that the BMI of most of the surveyed women did not indicate
obesity and were within the normal range BMI = 18.5–24.99.
Other publications, however, show a correlation between BMI
before pregnancy and mother’s lipid profile during the initial
phase of gestation, which also correlated with the child’s obe-
sity [33].
Also controversial is the question of the effects of inhibi-
tion of the synthesis of linoleic acid and α-linolenic acid by
TFAs. It is assumed that it may result in defects in fetal devel-
opment and low birth weight. Some authors claim that
inhibiting the synthesis of the aforementioned acids results
in a shorter pregnancy, having no effect on birth weight and
length of the body of the newborn. Others believe that the
result is lower birth weight and length of the body with a
normal duration of pregnancy.
A third position assumes that these three values are re-
duced, i.e. that the effects include low birth weight, shorter
body length, and a shorter duration of pregnancy. On this
basis, it is difficult to determine what exactly is affected by
TFA-induced inhibition of the synthesis of linoleic acid and
alpha-linolenic acid, although a negative impact on fetal de-
velopment is visible [17]. The results of our study showed no
correlation between the studied FAs and birth weight.
In this study, no correlation was observed between Pb
blood levels and the tested FAs, except for one case of a weak
correlation between the Pb in the blood of the newborn and
elaidic acid concentration in maternal blood. It is difficult to
discuss the obtained results because there are no studies on the
relationship between the concentration of blood FAs and Pb in
available literature. There are only reports on the link between
psychosocial disorders of children and the concentrations of
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Pb and FAs, which indicate a possible relationship between
these two variables. The authors of that paper showed that
children with elevated levels of blood Pb exhibited disorders
in psychosocial functioning at school and at home. The same
behavior was revealed in children with a reduced concentra-
tion of arachidonic acid, γ-linolenic acid, eicosapentaenoic
acid (EPA), and docosahexaenoic acid (DHA) levels [33].
To find a definite link between psychosocial disorders of chil-
dren and the concentrations of Pb and FAs, further research is
required to study correlations of Pb and TFA and the mecha-
nisms of their actions in the human body.
In our study, we found no correlation between maternal
blood Pb and low birth weight. This was probably due to the
low concentration of Pb in the blood of mothers, insufficient
to induce any such effect.
Exposure of children, adolescents, and adults to Pb nega-
tively correlates with BMI and obesity [34, 35]. Also our
study confirmed this correlation between the concentration
of Pb in the blood of mothers and mothers’ BMI before
pregnancy.
Conclusion
Our study established a significant and strong correlation be-
tween the content of Pb in the blood of the mother and the
child. This supports the assumption that the transport of Pb
through the placenta is neither regulated nor selective.
Environmental maternal exposure to lead resulting in Pb-B
within levels previously considered safe for pregnant women,
i.e., 5 μg/dL, had no effect on the concentration of fatty acids
in the blood and milk of mothers or in the blood of newborns.
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